Are you taking Amiodarone? Are you aware of the dangers of combining Amiodarone with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...

Amiodarone was discovered in 1961, but was not approved by the FDA until 1985. Although classified as a class III antiarrhythmic, amiodarone exhibits properties of class I, II and IV antiarrhythmics ...

Amiodarone is a benzofuran derivative approved for the treatment of cardiac arrhythmias. Traditionally classified as a class III antiarrhythmic agent, amiodarone possesses electrophysiologic ...

Ortiz and colleagues [2] sought to compare the efficacy of amiodarone vs procainamide in patients with hemodynamically stable, regular WCT. The exact diagnosis (eg, VT vs supraventricular tachycardia ...

The optimal pharmacologic means to restore and maintain sinus rhythm in patients with atrial fibrillation remains controversial. In this double-blind, placebo-controlled trial, we randomly assigned ...

Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter–defibrillator (ICD) has ...

This meta-analysis demonstrated that prophylactic amiodarone can increase a patient's odds of developing bradycardia by 70% and hypotension by 62%. However, not all safety endpoints were adversely ...

Blue man syndrome is a condition that presents with bluish gray hyperpigmentation of the skin due to long term administration of amiodarone. This is a rare side effects of the drug amiodarone. It ...

Background: Amiodarone is associated with dysfunction of the thyroid. Concerns have arisen regarding the potential for adverse effects with generic formulations of amiodarone. We evaluated and ...

The Case: A 66-year-old woman was admitted to hospital because of progressive dyspnea on exertion. At the time of admission, the patient became breathless on minimal activity. A high-grade ...

Mylan has issued a nationwide voluntary recall of injectable amiodarone, an antiarrhythmic for in-hospital use, that may have been mislabeled as tranexamic acid injection, according to the US Food and ...